Cargando…

Prognostic Model for Survival and Recurrence in Patients with Early-Stage Cervical Cancer: A Korean Gynecologic Oncology Group Study (KGOG 1028)

PURPOSE: We aimed to develop and validate individual prognostic models in a large cohort of cervical cancer patients that were primarily treated with radical hysterectomy. MATERIALS AND METHODS: We analyzed 1,441 patients with early-stage cervical cancer treated between 2000 and 2008 from the Korean...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paik, E Sun, Lim, Myong Cheol, Kim, Moon-Hong, Kim, Yun Hwan, Song, Eun Seop, Seong, Seok Ju, Suh, Dong Hoon, Lee, Jong-Min, Lee, Chulmin, Choi, Chel Hun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962474/ https://www.ncbi.nlm.nih.gov/pubmed/31401822 http://dx.doi.org/10.4143/crt.2019.124

Ejemplares similares

A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D
por: Lee, Jung-Yun, et al.
Publicado: (2019)

Pattern of practice for postoperative management of endometrial cancer in Korea: a survey by the Korean Gynecologic Oncology Group and the Korean Radiation Oncology Group (KGOG 2028-KROG 2104)
por: Lee, Sung Uk, et al.
Publicado: (2023)

A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/NIRVANA-R trial
por: Park, Junsik, et al.
Publicado: (2021)

The Prognostic Model of Pre-Treatment Complete Blood Count (CBC) for Recurrence in Early Cervical Cancer
por: Noh, Joseph J., et al.
Publicado: (2020)

Comparisons of survival outcomes between bevacizumab and olaparib in BRCA-mutated, platinum-sensitive relapsed ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG 3052)
por: Kim, Se Ik, et al.
Publicado: (2021)

The 5th Shanghai Gynecologic Oncology Group (SGOG)-Korean Gynecologic Oncology Group (KGOG) joint meeting and 2016 Asia-Pacific Ovarian cancer Laparotomy and Laparoscopic Operation (APOLLO) symposium in Shanghai
por: Chang, Ha Kyun, et al.
Publicado: (2016)

Minimally invasive surgery for radical hysterectomy in women with cervical cancer: Korean Society of Gynecologic Oncology, Korean Society of Obstetrics and Gynecology, and Korean Society of Gynecologic Endoscopy and Minimally Invasive Surgery position statement
por: Kim, Miseon, et al.
Publicado: (2019)

An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021)
por: Lee, Shin-Wha, et al.
Publicado: (2018)

Phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer: primary analysis in the original cohort of KGOG3046/TRU-D
por: Park, Junsik, et al.
Publicado: (2023)

Preventive vaccination against cervical cancer: Korean Society of Gynecologic Oncology Guideline
por: Min, Kyung-Jin, et al.
Publicado: (2016)

Surgical manual of the Korean Gynecologic Oncology Group: classification of hysterectomy and lymphadenectomy
por: Lee, Maria, et al.
Publicado: (2017)

Position statements on genetic test for peritoneal, ovarian, and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO)
por: Choi, Min Chul, et al.
Publicado: (2016)

Real-World Experience of Pembrolizumab Monotherapy in Patients with Recurrent or Persistent Cervical Cancer: A Korean Multi-Center Retrospective Study (KGOG1041)
por: Choi, Min Chul, et al.
Publicado: (2020)

Surgical manual of the Korean Gynecologic Oncology Group: ovarian, tubal, and peritoneal cancers
por: Jeon, Seob, et al.
Publicado: (2017)

A prospective randomized controlled trial evaluating the safety and efficacy of patient blood management program in patients with gynecologic cancer (KGOG 4011/PBM)
por: Park, Jeong-Yeol, et al.
Publicado: (2023)

The 34th Annual Meeting of the Korean Society of Gynecologic Oncology 2019: meeting report
por: Yim, Ga Won, et al.
Publicado: (2019)

Discrepancy between Cytology and Histology in Cervical Cancer Screening: a Multicenter Retrospective Study (KGOG 1040)
por: Ouh, Yung-Taek, et al.
Publicado: (2021)

High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology
por: Kong, Tae-Wook, et al.
Publicado: (2020)

High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology
por: Kong, Tae-Wook, et al.
Publicado: (2019)

An open-label, multicenter, phase I trial of a cremophor-free, polymeric micelle formulation of paclitaxel combined with carboplatin as a first-line treatment for advanced ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG-3016)
por: Lee, Shin-Wha, et al.
Publicado: (2017)

Controversies in the management of endometrial cancer: a survey of the Korean Gynecologic Oncology Group
por: Lee, Jung-Yun, et al.
Publicado: (2015)

Practice guidelines for management of cervical cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement
por: Lim, Myong Cheol, et al.
Publicado: (2017)

Modulated electro-hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial
por: Kim, Kidong, et al.
Publicado: (2021)

Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial
por: Lee, Jung-Yun, et al.
Publicado: (2022)

Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines
por: Cho, Hyun-Woong, et al.
Publicado: (2021)

Clinical guideline for 9-valent HPV vaccine: Korean Society of Gynecologic Oncology Guideline
por: Min, Kyung-Jin, et al.
Publicado: (2019)

Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement
por: Lee, Shin-Wha, et al.
Publicado: (2017)

Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition
por: Lee, Jae Kwan, et al.
Publicado: (2013)

Role of preoperative magnetic resonance imaging and histological assessment in identifying patients with a low risk of endometrial cancer: a Korean Gynecologic Oncology Group ancillary study
por: Lee, Jung-Yun, et al.
Publicado: (2017)

Six months response rate of combined oral medroxyprogesterone/levonorgestrel-intrauterine system for early-stage endometrial cancer in young women: a Korean Gynecologic-Oncology Group Study
por: Kim, Mi Kyoung, et al.
Publicado: (2019)

Informed consent forms for gynecologic cancer surgery: recommendations from the Korean Society of Gynecologic Oncology
por: Chang, Ha Kyun, et al.
Publicado: (2022)

Informed consent forms for gynecologic cancer surgery: recommendations from the Korean Society of Gynecologic Oncology
por: Chang, Ha Kyun, et al.
Publicado: (2022)

Practice guidelines for management of ovarian cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement
por: Suh, Dong Hoon, et al.
Publicado: (2018)

Randomized comparison between sentinel lymph node mapping using indocyanine green plus a fluorescent camera versus lymph node dissection in clinical stage I-II endometrial cancer: a Korean Gynecologic Oncology Group trial (KGOG2029/SELYE)
por: Park, Jeong-Yeol, et al.
Publicado: (2022)

Gleason score stratification according to age at diagnosis in 1028 men
por: Pepe, Pietro, et al.
Publicado: (2016)

1028. Dalbavancin Use in Complicated Infections and-associated Cost-Savings
por: Streifel, Amber C, et al.
Publicado: (2019)

Asian Society of Gynecologic Oncology International Workshop 2018
por: Kong, Tae-Wook, et al.
Publicado: (2019)

Efficacy of the multidisciplinary tumor board conference in gynecologic oncology: A prospective study
por: Lee, Banghyun, et al.
Publicado: (2017)

Initial Experience of Articulating Laparoscopic Instruments for Benign Gynecologic Disease: A Single-Arm Multicenter Prospective Study (Korean Gynecologic Oncology Group 4002)
por: Noh, Joseph J., et al.
Publicado: (2023)

Major clinical research advances in gynecologic cancer in 2012
por: Suh, Dong Hoon, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_t4c34en7kqj1oq6dino2prjqpt